228 related articles for article (PubMed ID: 24599011)
21. Valsartan inhibits NPC cell line CNE-2 proliferation and invasion and promotes its sensitivity to radiation.
Wang Q; Zhao W; Wu G
Eur J Cancer Prev; 2009 Nov; 18(6):510-7. PubMed ID: 19687742
[TBL] [Abstract][Full Text] [Related]
22. Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor γ among clinically used angiotensin II receptor blockers: drug-target interaction analyses.
Kakuta H; Kurosaki E; Niimi T; Gato K; Kawasaki Y; Suwa A; Honbou K; Yamaguchi T; Okumura H; Sanagi M; Tomura Y; Orita M; Yonemoto T; Masuzaki H
J Pharmacol Exp Ther; 2014 Apr; 349(1):10-20. PubMed ID: 24424487
[TBL] [Abstract][Full Text] [Related]
23. Valsartan ameliorates ageing-induced aorta degeneration via angiotensin II type 1 receptor-mediated ERK activity.
Shan H; Zhang S; Li X; Yu K; Zhao X; Chen X; Jin B; Bai X
J Cell Mol Med; 2014 Jun; 18(6):1071-80. PubMed ID: 24548645
[TBL] [Abstract][Full Text] [Related]
24. Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes.
Furukawa H; Mawatari K; Koyama K; Yasui S; Morizumi R; Shimohata T; Harada N; Takahashi A; Nakaya Y
Eur J Pharmacol; 2011 Jun; 660(2-3):485-91. PubMed ID: 21514293
[TBL] [Abstract][Full Text] [Related]
25. Valsartan blocked alcohol-induced, Toll-like receptor 2 signaling-mediated inflammation in human vascular endothelial cells.
Wang Y; Li Y; Shen Q; Li X; Lu J; Li X; Yin D; Peng Y
Alcohol Clin Exp Res; 2014 Oct; 38(10):2529-40. PubMed ID: 25346502
[TBL] [Abstract][Full Text] [Related]
26. Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes.
Kong P; Chi R; Zhang L; Wang N; Lu Y
Fitoterapia; 2013 Dec; 91():44-50. PubMed ID: 23978582
[TBL] [Abstract][Full Text] [Related]
27. Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites.
Schupp M; Lee LD; Frost N; Umbreen S; Schmidt B; Unger T; Kintscher U
Hypertension; 2006 Mar; 47(3):586-9. PubMed ID: 16365190
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
[TBL] [Abstract][Full Text] [Related]
29. Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models.
Tomono Y; Iwai M; Inaba S; Mogi M; Horiuchi M
Am J Hypertens; 2008 Feb; 21(2):206-12. PubMed ID: 18188158
[TBL] [Abstract][Full Text] [Related]
30. Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway.
Cheng CI; Hsiao CC; Wu SC; Peng SY; Yip HK; Fu M; Wang FS
Int J Cardiol; 2013 Sep; 167(6):2765-74. PubMed ID: 22805546
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: Relative to inhibition of inflammatory responses.
Kang L; Heng W; Yuan A; Baolin L; Fang H
Biochimie; 2010 Jul; 92(7):789-96. PubMed ID: 20188786
[TBL] [Abstract][Full Text] [Related]
32. Induction of human adiponectin gene transcription by telmisartan, angiotensin receptor blocker, independently on PPAR-gamma activation.
Moriuchi A; Yamasaki H; Shimamura M; Kita A; Kuwahara H; Fujishima K; Satoh T; Fukushima K; Fukushima T; Hayakawa T; Mizuguchi H; Nagayama Y; Abiru N; Kawasaki E; Eguchi K
Biochem Biophys Res Commun; 2007 May; 356(4):1024-30. PubMed ID: 17399685
[TBL] [Abstract][Full Text] [Related]
33. Different effects of telmisartan and valsartan on human aortic vascular smooth muscle cell proliferation.
Wang L; Zhao L; Zhang D; Chen JZ; Xue JL
Chin Med J (Engl); 2012 Jun; 125(12):2200-4. PubMed ID: 22884153
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.
Fujiwara Y; Shiraya S; Miyake T; Yamakawa S; Aoki M; Makino H; Nishimura M; Morishita R
Int J Mol Med; 2008 Dec; 22(6):703-8. PubMed ID: 19020766
[TBL] [Abstract][Full Text] [Related]
35. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis.
Mizushima T; Sasaki M; Ando T; Wada T; Tanaka M; Okamoto Y; Ebi M; Hirata Y; Murakami K; Mizoshita T; Shimura T; Kubota E; Ogasawara N; Tanida S; Kataoka H; Kamiya T; Alexander JS; Joh T
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G255-66. PubMed ID: 19940029
[TBL] [Abstract][Full Text] [Related]
36. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
Min Q; Bai YT; Jia G; Wu J; Xiang JZ
Exp Mol Pathol; 2010 Feb; 88(1):133-7. PubMed ID: 19796634
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
[TBL] [Abstract][Full Text] [Related]
38. Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.
Azuma K; Tamura K; Shigenaga A; Wakui H; Masuda S; Tsurumi-Ikeya Y; Tanaka Y; Sakai M; Matsuda M; Hashimoto T; Ishigami T; Lopez-Ilasaca M; Umemura S
Hypertension; 2007 Nov; 50(5):926-32. PubMed ID: 17875818
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells.
Sugawara A; Takeuchi K; Uruno A; Ikeda Y; Arima S; Kudo M; Sato K; Taniyama Y; Ito S
Endocrinology; 2001 Jul; 142(7):3125-34. PubMed ID: 11416035
[TBL] [Abstract][Full Text] [Related]
40. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Harada N; Shimozawa N; Okajima K
Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
